Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PEG-INTERFERON ALFA 2A Cause Renal failure acute? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Renal failure acute have been filed in association with PEG-INTERFERON ALFA 2A. This represents 3.8% of all adverse event reports for PEG-INTERFERON ALFA 2A.

10
Reports of Renal failure acute with PEG-INTERFERON ALFA 2A
3.8%
of all PEG-INTERFERON ALFA 2A reports
3
Deaths
6
Hospitalizations

How Dangerous Is Renal failure acute From PEG-INTERFERON ALFA 2A?

Of the 10 reports, 3 (30.0%) resulted in death, 6 (60.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.

Is Renal failure acute Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PEG-INTERFERON ALFA 2A. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does PEG-INTERFERON ALFA 2A Cause?

Anaemia (43) Pancytopenia (25) Leukopenia (21) Hepatitis c (19) Thrombocytopenia (17) Neutropenia (15) Rash (12) Fatigue (10) Pneumonia (9) Renal failure (9)

What Other Drugs Cause Renal failure acute?

METFORMIN (337) DABIGATRAN ETEXILATE (303) FUROSEMIDE (271) PRADAXA (193) RAMIPRIL (181) LISINOPRIL (169) SODIUM, DIBASIC\SODIUM, MONOBASIC (150) IBUPROFEN (128) SPIRONOLACTONE (117) SIMVASTATIN (107)

Which PEG-INTERFERON ALFA 2A Alternatives Have Lower Renal failure acute Risk?

PEG-INTERFERON ALFA 2A vs PEGASPARGASE PEG-INTERFERON ALFA 2A vs PEGASYS PEG-INTERFERON ALFA 2A vs PEGCETACOPLAN PEG-INTERFERON ALFA 2A vs PEGFILGRASTIM PEG-INTERFERON ALFA 2A vs PEGFILGRASTIM-APGF

Related Pages

PEG-INTERFERON ALFA 2A Full Profile All Renal failure acute Reports All Drugs Causing Renal failure acute PEG-INTERFERON ALFA 2A Demographics